11 studies found for:    lixisenatide | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
Condition: Type 2 Diabetes
Interventions: Drug: Insulin glargine/lixisenatide HOE901/AVE0010;   Drug: Insulin glargine HOE901;   Drug: Lixisenatide AVE0010;   Drug: Metformin
2 Recruiting Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: Lixisenatide;   Other: Placebo
3 Recruiting Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo
4 Recruiting Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: lixisenatide AVE0010;   Drug: biguanide;   Drug: TZD;   Drug: alpha-GI;   Drug: glinide
5 Recruiting Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo
6 Recruiting Study on Lixisenatide and Counterregulation to Hypoglycemia
Condition: Type 2 Diabetes
Intervention: Drug: Lixisenatide
7 Recruiting Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: lixisenatide AVE0010
8 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Insulin glargine/lixisenatide HOE901/AVE0010;   Drug: Insulin glargine HOE901;   Drug: Metformin
9 Not yet recruiting Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide;   Drug: Insulin glargine
10 Not yet recruiting Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LIXISENATIDE AVE0010;   Drug: Sitagliptin;   Drug: Insulin glargine HOE901
11 Recruiting Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
Condition: Diabetes Mellitus
Intervention: Drug: Luyxumia versus Lantus

Indicates status has not been verified in more than two years